88 results
8-K
EX-99.1
ARVN
Arvinas Inc
7 May 24
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:02am
vepdegestrant, ARV-766 and other product candidates on current timelines or at all; the satisfaction or waiver
of the closing conditions set forth
8-K
EX-99.1
ARVN
Arvinas Inc
11 Apr 24
Entry into a Material Definitive Agreement
7:03am
, including but not limited to: the satisfaction or waiver of the closing conditions set forth in the license agreement with Novartis, each party’s
8-K
ARVN
Arvinas Inc
11 Apr 24
Entry into a Material Definitive Agreement
7:03am
risks and uncertainties, including but not limited to: the satisfaction or waiver of the conditions to the closing of the License Agreement
S-8
EX-5.1
wr9kow
18 Mar 24
Registration of securities for employees
4:47pm
S-8
EX-5.1
uuy 7hzb2lwb1898
16 Jan 24
Registration of securities for employees
4:03pm
S-8
EX-99.3
r28u6 pvlap
16 Jan 24
Registration of securities for employees
4:03pm
S-8
EX-99.4
6cuo kvnedz2un3dcxg7
16 Jan 24
Registration of securities for employees
4:03pm
8-K
EX-10.1
s03vvw9xk 0f
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
8-K
4smr33
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
8-K
EX-4.1
ftt 6wergi
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
8-K
EX-99.1
adanlq3k50chns
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
S-3ASR
EX-4.4
4blplve
7 Nov 23
Automatic shelf registration
5:24pm
S-3ASR
EX-1.2
z4k40ov765 9tcsk1
7 Nov 23
Automatic shelf registration
5:24pm
S-3ASR
EX-4.5
uiorjabm
7 Nov 23
Automatic shelf registration
5:24pm
S-3ASR
ctvx86j
7 Nov 23
Automatic shelf registration
5:24pm